Sensus Healthcare Statistics
Total Valuation
SRTS has a market cap or net worth of $55.90 million. The enterprise value is $33.54 million.
| Market Cap | 55.90M |
| Enterprise Value | 33.54M |
Important Dates
The next confirmed earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SRTS has 16.39 million shares outstanding. The number of shares has decreased by -2.12% in one year.
| Shares Outstanding | 16.39M |
| Shares Change (YoY) | -2.12% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 21.39% |
| Owned by Institutions (%) | 17.05% |
| Float | 13.07M |
Valuation Ratios
The trailing PE ratio is 115.00 and the forward PE ratio is 75.16.
| PE Ratio | 115.00 |
| Forward PE | 75.16 |
| PS Ratio | 2.29 |
| Forward PS | 2.08 |
| PB Ratio | 1.14 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 69.15 |
| EV / Sales | 1.37 |
| EV / EBITDA | 30.13 |
| EV / EBIT | 51.44 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.76, with a Debt / Equity ratio of 0.02.
| Current Ratio | 11.76 |
| Quick Ratio | 8.02 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.70 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 1.00% and return on invested capital (ROIC) is -0.57%.
| Return on Equity (ROE) | 1.00% |
| Return on Assets (ROA) | 0.90% |
| Return on Capital (ROIC) | -0.57% |
| Revenue Per Employee | $697,286 |
| Profits Per Employee | $13,857 |
| Employee Count | 35 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 0.84 |
Taxes
In the past 12 months, SRTS has paid $167,000 in taxes.
| Income Tax | 167,000 |
| Effective Tax Rate | 25.61% |
Stock Price Statistics
The stock price has decreased by -26.28% in the last 52 weeks. The beta is 0.94, so SRTS's price volatility has been similar to the market average.
| Beta (1Y) | 0.94 |
| 52-Week Price Change | -26.28% |
| 50-Day Moving Average | 3.80 |
| 200-Day Moving Average | 3.03 |
| Relative Strength Index (RSI) | 47.89 |
| Average Volume (30 Days) | 147,012 |
Short Selling Information
The latest short interest is 33,382, so 0.20% of the outstanding shares have been sold short.
| Short Interest | 33,382 |
| Short Previous Month | 33,400 |
| Short % of Shares Out | 0.20% |
| Short % of Float | 0.26% |
| Short Ratio (days to cover) | 0.31 |
Income Statement
In the last 12 months, SRTS had revenue of $24.41 million and earned $485,000 in profits. Earnings per share was $0.03.
| Revenue | 24.41M |
| Gross Profit | 14.06M |
| Operating Income | -382,000 |
| Pretax Income | 652,000 |
| Net Income | 485,000 |
| EBITDA | 1.11M |
| EBIT | 652,000 |
| Earnings Per Share (EPS) | $0.03 |
Balance Sheet
The company has $23.15 million in cash and $783,000 in debt, giving a net cash position of $22.37 million or $1.36 per share.
| Cash & Cash Equivalents | 23.15M |
| Total Debt | 783,000 |
| Net Cash | 22.37M |
| Net Cash Per Share | $1.36 |
| Equity / Book Value | 48.84M |
| Book Value Per Share | 2.98 |
| Working Capital | 45.32M |
Cash Flow
In the last 12 months, operating cash flow was -$2.15 million and capital expenditures -$187,000, giving a free cash flow of -$2.33 million.
| Operating Cash Flow | -2.15M |
| Capital Expenditures | -187,000 |
| Free Cash Flow | -2.33M |
| FCF Per Share | -$0.14 |
Margins
Gross margin is 57.61%, with operating and profit margins of -1.57% and 1.99%.
| Gross Margin | 57.61% |
| Operating Margin | -1.57% |
| Pretax Margin | 2.67% |
| Profit Margin | 1.99% |
| EBITDA Margin | 4.56% |
| EBIT Margin | 2.67% |
| FCF Margin | -9.56% |
Dividends & Yields
SRTS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.12% |
| Shareholder Yield | 2.12% |
| Earnings Yield | 0.87% |
| FCF Yield | -4.17% |
Analyst Forecast
The average price target for SRTS is $7.50, which is 117.39% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.50 |
| Price Target Difference | 117.39% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SRTS has an Altman Z-Score of 8.57 and a Piotroski F-Score of 5.
| Altman Z-Score | 8.57 |
| Piotroski F-Score | 5 |